Tag: <span>diagnosis</span>

Post

Those infected in China could be up to four times more

According to a new study by researchers at the University of Hong Kong, the number of infected in mid-February in the Asian giant could have been up to four times higher than the official if a more extensive accounting method had been applied. On February 20, Chinese authorities reported 55,000 positive cases of COVID-19 across...

Post

Commercially available COVID-19 diagnostic tests

In the page Coronavirus Test Tracker, 360Dx is updating a list with assays to detect the SARS-CoV-2 coronavirus on a regular basis in order to provide readers with up-to-date and accurate information on the regulatory status of these tests in the US, European, and Asian markets. The tracker includes only those tests that are available...

Post

Abbott launches COVID-19 antibody test

Abbott has launched its third test for coronavirus (COVID-19) and will start shipping it in the U.S. The test is a serology test ―also called an antibody test―, which could be a critical next step in battling this virus. Abbott’s test helps to detect the IgG antibody to SARS-CoV-2. An antibody is a protein that...

Post

Siemens developing new diagnostic for COVID-19

The Erlangen, Germany-based company said its Fast Track Diagnostics (FTD) SARS-COV-2 Assay is already being shipped in Europe for research use only. Siemens Healthineers is looking at speaking with FDA to release the test under Emergency Use Authorization. Siemens Healthineers is adding more firepower in the fight to make more novel coronavirus (SARS-CoV-2) diagnostics available....

Post

Why is chest CT important for early diagnosis of COVID-19?

COVID-19 diagnosis is based on the identification of viral RNA through Reverse Transcription Polymerase Chain Reaction (RT-PCR) from oral-nasopharyngeal swabs, which however presents suboptimal sensitivity and may require several hours in overstressed laboratories. These drawbacks have called for an additional, complementary first line approach. Computed Tomography (CT) Scan is the gold standard method for the...

Post

Hologic’s molecular test for SARS-CoV-2 receives FDA Emergency Use Authorization

Hologic, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the Company’s new Panther Fusion® SARS-CoV-2 assay, a molecular diagnostic test that detects SARS-CoV-2, the virus that causes COVID-19 disease. Hospital, public health and reference laboratories can perform the test on Hologic’s Panther Fusion system, a...